HPE
44
-2
HP
37
3
AKAM
45
-2
TSN
38
3
MRO
42
6
PNC
45
4
PNW
45
-4
CF
42
6
XOM
48
3
VIX
33
3
PEG
46
5
VFC
58
13
FITB
50
2
MPC
47
3
CHRW
44
2
LRCX
71
-6
MNST
59
3
ED
33
3
WEC
50
5
DVN
25
7
HPE
44
-2
HP
37
3
AKAM
45
-2
TSN
38
3
MRO
42
6
PNC
45
4
PNW
45
-4
CF
42
6
XOM
48
3
VIX
33
3
PEG
46
5
VFC
58
13
FITB
50
2
MPC
47
3
CHRW
44
2
LRCX
71
-6
MNST
59
3
ED
33
3
WEC
50
5
DVN
25
7
Financhill
Back

GeoPark Vs. Ultragenyx Pharmaceutical Industry Stock Comparison

Buy
56

GPRK
GeoPark

Last Price:
11.21
Seasonality Move:
-5.03%
Sell
43

RARE
Ultragenyx Pharmaceutical

Last Price:
39.82
Seasonality Move:
-0.9%
Buy
56
GeoPark (GPRK) is a Buy

Is GeoPark a Buy, Sell or Hold?

  • The current GeoPark [GPRK] share price is $11.09. The Score for GPRK is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
  • GPRK is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
43
Ultragenyx Pharmaceutical (RARE) is a Sell

Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?

  • The current Ultragenyx Pharmaceutical [RARE] share price is $39.39. The Score for RARE is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
  • RARE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

GPRK Stock Price Chart

What is GeoPark's stock price today?

  • The GeoPark share price today is $11.09
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and GPRK is experiencing buying pressure, which is a positive indicator for future bullish movement.

RARE Stock Price Chart

What is Ultragenyx Pharmaceutical's stock price today?

  • The Ultragenyx Pharmaceutical share price today is $39.39
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RARE is experiencing selling pressure, which indicates risk of future bearish movement.

GPRK Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.23 Buy
Relative Strength Index (14 RSI): 72.18 Buy
Chaikin Money Flow: 754005 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (10.04 - 10.58) Buy
Bollinger Bands (100): (8.82 - 10.18) Buy

RARE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.74 Sell
Relative Strength Index (14 RSI): 45.16 Sell
Chaikin Money Flow: -377368 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (38.89 - 42.13) Sell
Bollinger Bands (100): (40.93 - 48.81) Sell

GPRK Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 10.55 Buy
20-day SMA: 10.37 Buy
50-day SMA: 9.97 Buy
200-day SMA: 9.46 Buy
8-day EMA: 10.64 Buy
20-day EMA: 10.4 Buy
50-day EMA: 10.05 Buy
200-day EMA: 9.79 Buy

RARE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 40.13 Sell
20-day SMA: 40.38 Sell
50-day SMA: 41.72 Sell
200-day SMA: 42.46 Sell
8-day EMA: 39.68 Sell
20-day EMA: 40.43 Sell
50-day EMA: 41.92 Sell
200-day EMA: 43.42 Sell

GeoPark Earnings Growth & GPRK Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.13 per share, and an increase next year of $0.20 per share.

Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.49 per share, an increase next quarter of $0.01 per share, an increase this year of $0.90 per share, and an increase next year of $1.07 per share.

GeoPark Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Ultragenyx Pharmaceutical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):